Paul Kim

Paul Kim

Director of Finance/CFO at FULGENT GENETICS, INC.

Net worth: 5 M $ as of 2024-03-30

56 year
Health Technology
Commercial Services
Health Services

Profile

Paul H.
Kim
is currently the Chief Executive Officer at Matica Biotechnology, Inc., the Director at Exagen, Inc., the Chief Financial Officer at Fulgent Therapeutics LLC, and the Chief Financial Officer at Fulgent Genetics, Inc. He previously worked as a Director at WCCT Global, Inc. and PharmAbcine Inc., a Principal at Heron Therapeutics, Inc., a Controller at Interlink Computer Sciences, Inc., the Chief Financial Officer at AMCC Enterprise Corp., the Chief Financial Officer at Gemalto Cogent, Inc., an Audit Manager at Coopers & Lybrand LLP, a Principal at CG Invites Co., Ltd., a Principal at Viro-Med Laboratories, Inc., the Chief Financial Officer at Cogent, Inc., and the Vice President-Finance & Administration at Datafusion, Inc. Mr. Kim received his undergraduate degree from the University of California, Berkeley and his MBA from the Tuck School of Business at Dartmouth.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-25 219,672 ( 0.74% ) 5 M $ 2024-03-30

Paul Kim active positions

CompaniesPositionStart
FULGENT GENETICS, INC. Director of Finance/CFO 2015-12-31
EXAGEN INC. Director/Board Member 2023-07-23
Director of Finance/CFO 2015-12-31
Matica Biotechnology, Inc. Chief Executive Officer 2024-02-04
All active positions of Paul Kim

Former positions of Paul Kim

CompaniesPositionEnd
Director of Finance/CFO 2014-12-31
Director of Finance/CFO 2010-12-31
Director of Finance/CFO 2003-11-30
Datafusion, Inc. Director of Finance/CFO 1999-09-30
Comptroller/Controller/Auditor 1997-12-31
See the detail of Paul Kim's experience

Training of Paul Kim

University of California, Berkeley Undergraduate Degree
Tuck School of Business at Dartmouth Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Kim's experience

Connections

100 +

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
HERON THERAPEUTICS, INC.

Health Technology

EXAGEN INC.

Health Services

CRYSTALGENOMICS INVITES CO., LTD.

Health Technology

PHARMABCINE INC.

Health Technology

FULGENT GENETICS, INC.

Health Services

Private companies10

Technology Services

Electronic Technology

Electronic Technology

Coopers & Lybrand LLP

Commercial Services

Commercial Services

Producer Manufacturing

Datafusion, Inc.

Commercial Services

Health Services

Matica Biotechnology, Inc.

See company connections